On the contrary, high-affinity binding of ApoE to C1q attenuates the activity of C1q both on Aβ and atherosclerotic plaques, suggesting that ApoE expression may mitigate the pathological effects of C1q both in AD and AS [79]. This evidence concerns the gene APOE and Alzheimer disease.